Cargando…
Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia
[Image: see text] Profiling of the kinase-binding capabilities of an aminopyrimidine analogue detected in a cellular screen of the St. Jude small-molecule collection led to the identification of a novel series of FMS-like tyrosine kinase 3 (FLT3) inhibitors. Structure–activity relationship studies l...
Autores principales: | Jarusiewicz, Jamie A., Jeon, Jae Yoon, Connelly, Michele C., Chen, Yizhe, Yang, Lei, Baker, Sharyn D., Guy, R. Kiplin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452050/ https://www.ncbi.nlm.nih.gov/pubmed/28580438 http://dx.doi.org/10.1021/acsomega.7b00144 |
Ejemplares similares
-
FLT3 inhibitors in acute myeloid leukemia
por: Wu, Mei, et al.
Publicado: (2018) -
Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
por: Lee, Hyo Jeong, et al.
Publicado: (2017) -
Clinical use of FLT3 inhibitors in acute myeloid leukemia
por: Sutamtewagul, Grerk, et al.
Publicado: (2018) -
FLT3 inhibitors: clinical potential in acute myeloid leukemia
por: Hospital, Marie-Anne, et al.
Publicado: (2017) -
Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
por: Ge, Shuai-Shuai, et al.
Publicado: (2022)